Greenstreet Yvonne's Form 4 filing
Alnylam Pharmaceuticals, Inc. (ALNY) · filed Aug 19, 2025
- Accession no.
- 0001735276-25-000089
- Filed
- Aug 19, 2025
- Trade date
- Aug 15-18, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 9 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.16M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Greenstreet YvonneCIK 0001446125 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | Common Stock | AGrant or awardAcquired | +14,252 | $0.00 | $0 | 63,200 | Direct | |
| Aug 18, 2025 | Common Stock | SSaleDisposed | −194 | $447.98 | −$86,908.12 | 63,006 | Direct | |
| Aug 18, 2025 | Common Stock | SSaleDisposed | −450 | $449.92 | −$202,464 | 62,556 | Direct | |
| Aug 18, 2025 | Common Stock | SSaleDisposed | −195 | $450.92 | −$87,929.4 | 62,361 | Direct | |
| Aug 18, 2025 | Common Stock | SSaleDisposed | −514 | $451.99 | −$232,322.86 | 61,847 | Direct | |
| Aug 18, 2025 | Common Stock | SSaleDisposed | −1,646 | $452.96 | −$745,572.16 | 60,201 | Direct | |
| Aug 18, 2025 | Common Stock | SSaleDisposed | −2,716 | $454.04 | −$1,233,172.64 | 57,485 | Direct | |
| Aug 18, 2025 | Common Stock | SSaleDisposed | −1,204 | $454.84 | −$547,627.36 | 56,281 | Direct | |
| Aug 18, 2025 | Common Stock | SSaleDisposed | −60 | $455.82 | −$27,349.2 | 56,221 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.